Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Autoimmune Disorders

Free Subscription 20.05.2024 1 Am J Kidney Dis 1 Ann Neurol 1 Brain 5 Diabet Med 2 Diabetes Res Clin Pract 3 Intern Med 9 J Autoimmun 1 J Clin Endocrinol Metab 2 J Neuroimmunol 3 J Neurol 3 J Rheumatol 3 Lancet Neurol 6 Mult Scler 1 N Engl J Med 2 Neurology 1 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Kidney Dis

1. SASAKI T, Tsuboi N
   Time-Varying Proteinuria in Predicting Outcome of IgA Nephropathy.
   Am J Kidney Dis. 2024 May 11:S0272-6386(24)00755.
   PubMed        
   
   

   
   Ann Neurol

2. GIORDANO A, Pignolet B, Mascia E, Clarelli F, et al
   DNA Methylation in the Anti-Mullerian Hormone Gene and the Risk of Disease Activity in Multiple Sclerosis.
   Ann Neurol. 2024 May 15. doi: 10.1002/ana.26959.
   PubMed         Abstract available
   
   

   
   Brain

3. JAMET Z, Mergaux C, Meras M, Bouchet D, et al
   NMDA receptor autoantibodies primarily impair the extrasynaptic compartment.
   Brain. 2024 May 17:awae163. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   Diabet Med

4. NEUMAN V, Piona C, Cudizio L, Drnkova L, et al
   Are we ready to screen for type 1 diabetes? A structured worldwide survey among healthcare providers involved in paediatric diabetes care.
   Diabet Med. 2024 Apr 2:e15329. doi: 10.1111/dme.15329.
   PubMed        
   
   
5. MERWIN RM, Dmitrieva NO, Moskovich AA, Warnick JL, et al
   Profiles of disordered eating behaviour in type 1 diabetes using the DEPS-R and behaviour and glycaemic outcomes in a real-life setting.
   Diabet Med. 2024 Mar 7:e15314. doi: 10.1111/dme.15314.
   PubMed         Abstract available
   
   
6. HEALEY A, Soukup T, Sevdalis N, Bakolis I, et al
   Cost-effectiveness of a Novel Hypoglycaemia Programme: The 'HARPdoc vs BGAT' RCT.
   Diabet Med. 2024;41:e15304.
   PubMed         Abstract available
   
   
7. FRANCESCHI R, Pertile R, Marigliano M, Mozzillo E, et al
   Satisfaction with continuous glucose monitoring is associated with quality of life in young people with type 1 diabetes regardless of metabolic control and treatment type.
   Diabet Med. 2024 Feb 21:e15307. doi: 10.1111/dme.15307.
   PubMed         Abstract available
   
   
8. SANDIN S, Jarnbert-Pettersson H, Persson M
   Preterm delivery and maternal obesity remain common complications in pregnancies with type 1 diabetes-A nationwide study in Sweden.
   Diabet Med. 2024 Jan 11:e15278. doi: 10.1111/dme.15278.
   PubMed         Abstract available
   
   

   
   Diabetes Res Clin Pract

9. SLOMINSKI B, Skrzypkowska M, Mysliwiec M, Trzonkowski P, et al
   Associations of the obesity gene FTO variant with complications and comorbidities in patients with type 1 diabetes.
   Diabetes Res Clin Pract. 2024;211:111683.
   PubMed         Abstract available
   
   
10. MURILLO S, Brugnara L, Rios S, Ribas V, et al
    People with type 1 diabetes exhibit lower exercise capacity compared to a control population with similar physical activity levels.
    Diabetes Res Clin Pract. 2024;211:111655.
    PubMed         Abstract available
    
    

    
    Intern Med

11. UMEMOTO D, Kanzawa Y, Nakamura T, Nishino I, et al
    Immune-mediated Necrotizing Myopathy in a Patient with Microscopic Polyangiitis.
    Intern Med. 2024;63:1485-1490.
    PubMed         Abstract available
    
    
12. SAITO K, Temmoku J, Sumichika Y, Yoshida S, et al
    Successful Treatment of Ultrasound-confirmed Synovitis in Anti-MDA5 Antibody-positive Clinically Amyopathic Dermatomyositis with Corticosteroid Therapy.
    Intern Med. 2024;63:1473-1478.
    PubMed         Abstract available
    
    
13. HORINO T, Inotani S, Komori M, Ohnishi H, et al
    Neuropsychiatric Systemic Lupus Erythematosus in a Patient with Pancytopenia and Chronic Schizophrenia Requiring Hospitalisation.
    Intern Med. 2024 May 16. doi: 10.2169/internalmedicine.3202.
    PubMed         Abstract available
    
    

    
    J Autoimmun

14. LIN M, Huang L, Huang J, Yu J, et al
    Modulation of PKM2 inhibits follicular helper T cell differentiation and ameliorates inflammation in lupus-prone mice.
    J Autoimmun. 2024;145:103198.
    PubMed         Abstract available
    
    
15. HEMON M, Giassi M, Ghaffar Y, Martin M, et al
    Microchimeric cells promote production of rheumatoid arthritis-specific autoantibodies.
    J Autoimmun. 2024;146:103238.
    PubMed         Abstract available
    
    
16. ESTUPINAN-MORENO E, Hernandez-Rodriguez J, Li T, Ciudad L, et al
    Decoding CD4(+) T cell transcriptome in giant cell arteritis: Novel pathways and altered cross-talk with monocytes.
    J Autoimmun. 2024;146:103240.
    PubMed         Abstract available
    
    
17. AKATSU C, Tsuneshige T, Numoto N, Long W, et al
    CD72 is an inhibitory pattern recognition receptor that recognizes ribosomes and suppresses production of anti-ribosome autoantibody.
    J Autoimmun. 2024;146:103245.
    PubMed         Abstract available
    
    
18. DAS S, Stamnaes J, Hoydahl LS, Skagen C, et al
    Selective activation of naive B cells with unique epitope specificity shapes autoantibody formation in celiac disease.
    J Autoimmun. 2024;146:103241.
    PubMed         Abstract available
    
    
19. YANG Y, Jiang H, Tang Z, Pan H, et al
    Assessment of the 2023 ACR/EULAR antiphospholipid syndrome classification criteria in a Chinese cohort: Impact on clinical practice.
    J Autoimmun. 2024;146:103237.
    PubMed         Abstract available
    
    
20. WANG K, Hou X, Lu H, Han N, et al
    Ectopic CD4(+) T cells in choroid plexus mediate neuropsychiatric lupus symptoms in mice via interferon-gamma induced microglia activation.
    J Autoimmun. 2024;145:103199.
    PubMed         Abstract available
    
    
21. GARCIA-LOZA I, Perna-Barrull D, Aguilera E, Almenara-Fuentes L, et al
    Targeting macrophages with phosphatidylserine-rich liposomes as a potential antigen-specific immunotherapy for type 1 diabetes.
    J Autoimmun. 2024;145:103196.
    PubMed         Abstract available
    
    
22. ZOU X, Huo F, Sun L, Huang J, et al
    Peripheral helper T cells in human diseases.
    J Autoimmun. 2024;145:103218.
    PubMed         Abstract available
    
    

    
    J Clin Endocrinol Metab

23. ZHANG Z, Luo S, Xiao Z, Yin W, et al
    Hsa_circRNA_405498 and hsa_circRNA_100033 serve as potential biomarkers for differential diagnosis of type 1 diabetes.
    J Clin Endocrinol Metab. 2023 Dec 29:dgad761. doi: 10.1210.
    PubMed         Abstract available
    
    

    
    J Neuroimmunol

24. CARVER JJ, Pugh BA, Lau KM, Didonna A, et al
    Lipid metabolism is dysregulated in endocrine glands upon autoimmune demyelination.
    J Neuroimmunol. 2024;391:578366.
    PubMed         Abstract available
    
    
25. DAMMAN S, Sukpornchairak P, Ahituv A, Chen A, et al
    Unilateral cortical autoimmune encephalitis: A case series and comparison to late-onset Rasmussen's encephalitis.
    J Neuroimmunol. 2024;391:578350.
    PubMed         Abstract available
    
    

    
    J Neurol

26. CORTESE R, Battaglini M, Stromillo ML, Luchetti L, et al
    Regional hippocampal atrophy reflects memory impairment in patients with early relapsing remitting multiple sclerosis.
    J Neurol. 2024 May 14. doi: 10.1007/s00415-024-12290.
    PubMed         Abstract available
    
    
27. WOLF E, Wicklein R, Aly L, Schmaderer C, et al
    Optical coherence tomography angiography suggests different retinal pathologies in multiple sclerosis and Sjogren's syndrome.
    J Neurol. 2024 May 14. doi: 10.1007/s00415-024-12414.
    PubMed         Abstract available
    
    
28. FREEDMAN DE, Oh J, Kiss A, Puopolo J, et al
    The influence of depression and anxiety on cognition in people with multiple sclerosis: a cross-sectional analysis.
    J Neurol. 2024 May 11. doi: 10.1007/s00415-024-12409.
    PubMed         Abstract available
    
    

    
    J Rheumatol

29. KANIECKI T, Moyers B, Lubinus M, Hu YP, et al
    Patient Perspectives of the Manifestations and Treatment of Anti-MDA5 Antibody-Positive Dermatomyositis: An Observational Survey.
    J Rheumatol. 2024 May 15:jrheum.2024-0108. doi: 10.3899/jrheum.2024-0108.
    PubMed         Abstract available
    
    
30. AKPOIGBE O, Anim-Koranteng C, Tasmin R, Sammut A, et al
    A Rare Case of Anti-Mi-2 Antibody-Positive Dermatomyositis Associated With Gastrointestinal Stromal Tumor.
    J Rheumatol. 2024 May 15:jrheum.2024-0114. doi: 10.3899/jrheum.2024-0114.
    PubMed         Abstract available
    
    
31. AVASARALA J, Das S, Keshavamurthy S
    Point-of-Care Ultrasound With Artificial Intelligence-Driven Diagnostics in Giant Cell Arteritis: Blindness Prevention on a Global Scale.
    J Rheumatol. 2024 May 15:jrheum.2024-0217. doi: 10.3899/jrheum.2024-0217.
    PubMed         Abstract available
    
    

    
    Lancet Neurol

32. ZHANG C, Shi FD
    Targeting B cells in neuromyelitis optica spectrum disorder.
    Lancet Neurol. 2024;23:549-550.
    PubMed        
    
    
33. CREE BAC, Kim HJ, Weinshenker BG, Pittock SJ, et al
    Safety and efficacy of inebilizumab for the treatment of neuromyelitis optica spectrum disorder: end-of-study results from the open-label period of the N-MOmentum trial.
    Lancet Neurol. 2024;23:588-602.
    PubMed         Abstract available
    
    
34. HAGHIKIA A, Schett G, Mougiakakos D
    B cell-targeting chimeric antigen receptor T cells as an emerging therapy in neuroimmunological diseases.
    Lancet Neurol. 2024;23:615-624.
    PubMed         Abstract available
    
    

    
    Mult Scler

35. LEBRUN-FRENAY C, Okuda DT
    Time to move past typical syndromes in the diagnosis of multiple sclerosis.
    Mult Scler. 2024 May 15:13524585241253519. doi: 10.1177/13524585241253519.
    PubMed        
    
    
36. WICKLEIN R, Kreitner L, Wild A, Aly L, et al
    Retinal small vessel pathology is associated with disease burden in multiple sclerosis.
    Mult Scler. 2024 May 15:13524585241247775. doi: 10.1177/13524585241247775.
    PubMed         Abstract available
    
    
37. NAIZER H, Wozny J, Krause TM, Huson E, et al
    Trends in central nervous system-active polypharmacy among people with multiple sclerosis.
    Mult Scler. 2024 May 15:13524585241251986. doi: 10.1177/13524585241251986.
    PubMed         Abstract available
    
    
38. HEWARD KD, Roy-Hewitson C, Solomon AJ
    Multiple sclerosis presenting with paroxysmal symptoms: Patients at the limitations of current diagnostic criteria.
    Mult Scler. 2024 May 15:13524585241253513. doi: 10.1177/13524585241253513.
    PubMed         Abstract available
    
    
39. COLLORONE S, Coll L, Lorenzi M, Llado X, et al
    Artificial intelligence applied to MRI data to tackle key challenges in multiple sclerosis.
    Mult Scler. 2024 May 13:13524585241249422. doi: 10.1177/13524585241249422.
    PubMed         Abstract available
    
    
40. DAGNEW B, Laslett LL, Honan CA, Blizzard L, et al
    The association of comorbidities with sleep quality among Australians with multiple sclerosis: Insights from the Australian Multiple Sclerosis Longitudinal Study.
    Mult Scler. 2024 May 13:13524585241248278. doi: 10.1177/13524585241248278.
    PubMed         Abstract available
    
    

    
    N Engl J Med

41. DOUGHTY CT, Schaefer PW, Brizzi K, Linnoila JJ, et al
    Case 14-2024: A 30-Year-Old Woman with Back Pain, Leg Stiffness, and Falls.
    N Engl J Med. 2024;390:1712-1719.
    PubMed        
    
    

    
    Neurology

42. PALLADINO R, Monasta L
    Estimating the Prevalence and Burden of Multiple Sclerosis in China Using the Global Burden of Disease Study: Challenges and Future Directions.
    Neurology. 2024;102:e209521.
    PubMed        
    
    
43. ZHANG C, Liu W, Wang L, Wang F, et al
    Prevalence and Burden of Multiple Sclerosis in China, 1990-2019: Findings From the Global Burden of Disease Study 2019.
    Neurology. 2024;102:e209351.
    PubMed         Abstract available
    
    

    
    PLoS One

44. LEE YH, Song GG
    Platelet-to-lymphocyte ratio as a biomarker of systemic inflammation in systemic lupus erythematosus: A meta-analysis and systematic review.
    PLoS One. 2024;19:e0303665.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Autoimmune Disorders is free of charge.